skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Discovery of the First-in-Class G9a/GLP Covalent Inhibitors

Journal Article · · J. Med. Chem.

Research Organization:
Argonne National Lab. (ANL), Argonne, IL (United States). Advanced Photon Source (APS)
Sponsoring Organization:
DOE - Office Of Science; National Institutes of Health (NIH)
OSTI ID:
1900776
Journal Information:
J. Med. Chem., Vol. 65, Issue (15)
Country of Publication:
United States
Language:
ENGLISH

References (68)

Histone lysine methyltransferases in biology and disease journal October 2019
Histone Lysine Methylation Dynamics: Establishment, Regulation, and Biological Impact journal November 2012
Epigenetics and beyond: targeting writers of protein lysine methylation to treat disease journal January 2021
Critical roles of non-histone protein lysine methylation in human tumorigenesis journal January 2015
Emerging roles of lysine methylation on non-histone proteins journal July 2015
Lysine Methylation Regulators Moonlighting outside the Epigenome journal September 2019
Chemical and Biochemical Perspectives of Protein Lysine Methylation journal June 2018
Inhibitors of Protein Methyltransferases and Demethylases journal March 2017
Selective Inhibitors of Protein Methyltransferases journal December 2014
Regulation of Estrogen Receptor α by the SET7 Lysine Methyltransferase journal May 2008
Regulation of p53 activity through lysine methylation journal November 2004
Critical roles of SMYD2-mediated β-catenin methylation for nuclear translocation and activation of Wnt signaling journal July 2017
Enhanced HSP70 lysine methylation promotes proliferation of cancer cells through activation of Aurora kinase B journal January 2012
SET1A-Mediated Mono-Methylation at K342 Regulates YAP Activation by Blocking Its Nuclear Export and Promotes Tumorigenesis journal July 2018
Tri-methylation of ATF7IP by G9a/GLP recruits the chromodomain protein MPP8 journal October 2018
Structure of the UHRF1 Tandem Tudor Domain Bound to a Methylated Non-histone Protein, LIG1, Reveals Rules for Binding and Regulation journal March 2019
Setd5is essential for mammalian development and co-transcriptional regulation of histone acetylation journal January 2016
ZMYND11 links histone H3.3K36me3 to transcription elongation and tumour suppression journal March 2014
SETD2 mutations in primary central nervous system tumors journal November 2018
The Role of Nuclear Receptor–Binding SET Domain Family Histone Lysine Methyltransferases in Cancer journal February 2017
ASH1L Links Histone H3 Lysine 36 Dimethylation to MLL Leukemia journal May 2016
KMT9 monomethylates histone H4 lysine 12 and controls proliferation of prostate cancer cells journal May 2019
Nonhistone Lysine Methylation in the Regulation of Cancer Pathways journal August 2016
Lysine methylation signaling of non-histone proteins in the nucleus journal May 2019
The role of histone methylation in the development of digestive cancers: a potential direction for cancer management journal August 2020
Histone Lysine Methylases and Demethylases in the Landscape of Human Developmental Disorders journal January 2018
CHARGE and Kabuki Syndromes: Gene-Specific DNA Methylation Signatures Identify Epigenetic Mechanisms Linking These Clinically Overlapping Conditions journal May 2017
Shifts in podocyte histone H3K27me3 regulate mouse and human glomerular disease journal December 2017
G9a histone methyltransferase plays a dominant role in euchromatic histone H3 lysine 9 methylation and is essential for early embryogenesis journal July 2002
Distinct Roles for Histone Methyltransferases G9a and GLP in Cancer Germ-Line Antigen Gene Regulation in Human Cancer Cells and Murine Embryonic Stem Cells journal June 2009
Mechanism of G9a inhibitor BIX-01294 acting on U251 glioma cells journal October 2016
MYC Interacts with the G9a Histone Methyltransferase to Drive Transcriptional Repression and Tumorigenesis journal October 2018
The H3K9 methyltransferase G9a is a marker of aggressive ovarian cancer that promotes peritoneal metastasis journal August 2014
G9a Promotes Invasion and Metastasis of Non–Small Cell Lung Cancer through Enhancing Focal Adhesion Kinase Activation via NF-κB Signaling Pathway journal March 2021
Inhibition of G9a by a small molecule inhibitor, UNC0642, induces apoptosis of human bladder cancer cells journal February 2019
Inhibition of a G9a/DNMT network triggers immune-mediated bladder cancer regression journal July 2019
Gain-of-Function Genetic Alterations of G9a Drive Oncogenesis journal July 2020
G9a controls pluripotent-like identity and tumor-initiating function in human colorectal cancer journal December 2020
Methyltransferase G9A regulates T cell differentiation during murine intestinal inflammation journal March 2014
Pharmacological inhibition of G9a/GLP restores cognition and reduces oxidative stress, neuroinflammation and β-Amyloid plaques in an early-onset Alzheimer’s disease mouse model journal December 2019
Inhibition of EHMT1/2 rescues synaptic and cognitive functions for Alzheimer’s disease journal January 2019
Inhibition of G9a methyltransferase stimulates fetal hemoglobin production by facilitating LCR/γ-globin looping journal July 2015
Targeting the histone methyltransferase G9a activates imprinted genes and improves survival of a mouse model of Prader–Willi syndrome journal December 2016
Adding a Lysine Mimic in the Design of Potent Inhibitors of Histone Lysine Methyltransferases journal July 2010
A chemical probe selectively inhibits G9a and GLP methyltransferase activity in cells journal July 2011
Optimization of Cellular Activity of G9a Inhibitors 7-Aminoalkoxy-quinazolines journal September 2011
Discovery of an in Vivo Chemical Probe of the Lysine Methyltransferases G9a and GLP journal October 2013
Discovery and Development of Potent and Selective Inhibitors of Histone Methyltransferase G9a journal January 2014
Discovery of a Novel Chemotype of Histone Lysine Methyltransferase EHMT1/2 (GLP/G9a) Inhibitors: Rational Design, Synthesis, Biological Evaluation, and Co-crystal Structure journal February 2019
Discovery of a 2,4-Diamino-7-aminoalkoxyquinazoline as a Potent and Selective Inhibitor of Histone Lysine Methyltransferase G9a journal December 2009
Protein Lysine Methyltransferase G9a Inhibitors: Design, Synthesis, and Structure Activity Relationships of 2,4-Diamino-7-aminoalkoxy-quinazolines. journal August 2010
Reversal of H3K9me2 by a Small-Molecule Inhibitor for the G9a Histone Methyltransferase journal February 2007
Discovery of novel histone lysine methyltransferase G9a/GLP (EHMT2/1) inhibitors: Design, synthesis, and structure-activity relationships of 2,4-diamino-6-methylpyrimidines journal October 2020
Discovery of DS79932728: A Potent, Orally Available G9a/GLP Inhibitor for Treating β-Thalassemia and Sickle Cell Disease journal December 2020
Novel SAR for quinazoline inhibitors of EHMT1 and EHMT2 journal September 2019
Discovery of first-in-class reversible dual small molecule inhibitors against G9a and DNMTs in hematological malignancies journal May 2017
Discovery of Potent and Selective Inhibitors for G9a-Like Protein (GLP) Lysine Methyltransferase journal February 2017
Structure-activity relationship studies of G9a-like protein (GLP) inhibitors journal August 2017
Targeting Epigenetic Regulators with Covalent Small-Molecule Inhibitors journal February 2021
Discovery of a First-in-Class Protein Arginine Methyltransferase 6 (PRMT6) Covalent Inhibitor journal May 2020
Structure-Based Design of a Covalent Inhibitor of the SET Domain-Containing Protein 8 (SETD8) Lysine Methyltransferase journal October 2016
Identification of 2,4-diamino-6,7-dimethoxyquinoline derivatives as G9a inhibitors journal January 2014
A coupled fluorescent assay for histone methyltransferases journal July 2005
Rapid Synthesis of Aryl Azides from Aryl Halides under Mild Conditions journal January 2005
Quinazoline-1-deoxynojirimycin hybrids as high active dual inhibitors of EGFR and α-glucosidase journal September 2017
Synthesis of enantiopure β2-homoalanine derivatives via rhodium catalyzed asymmetric hydrogenation journal April 2013
Senolytic activity of piperlongumine analogues: Synthesis and biological evaluation journal August 2018
Discovery of Reversible DNA Methyltransferase and Lysine Methyltransferase G9a Inhibitors with Antitumoral in Vivo Efficacy journal June 2018